EDRH
ICPT

Edmond de Rothschild Holding’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Edmond de Rothschild Holding’s Portfolio ICPT Stock Details ICPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-33,300
Closed -$5.52M – 889
2015
Q3 		$5.52M Buy
33,300
+2,450
+8% +$539K 0.14% 139
2015
Q2 		$7.45M Buy
+30,850
New +$8.22M 0.16% 122

Other funds holding ICPT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Edmond de Rothschild Holding's ICPT Position: Q4 2015 in Review

Edmond de Rothschild Holding sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q4 2015, closing a stake of 33,300 shares — an estimated $5.52M sold.

Edmond de Rothschild Holding first reported a position in ICPT in Q2 2015 and held it in 2 quarters. The position peaked at $7.45M in Q2 2015. 172 funds tracked by Wall St. Rank hold ICPT as of Q4 2015.

  • Edmond de Rothschild Holding reported no remaining Intercept Pharmaceuticals, Inc. position as of Q4 2015 after selling out during the quarter.
  • Edmond de Rothschild Holding sold 33,300 Intercept Pharmaceuticals, Inc. shares in Q4 2015, an estimated $5.52M.
  • Edmond de Rothschild Holding first reported a position in Intercept Pharmaceuticals, Inc. in Q2 2015 and held it in 2 quarters.
  • Edmond de Rothschild Holding's Intercept Pharmaceuticals, Inc. position peaked at $7.45M in Q2 2015.
  • 172 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2015.

Based on Edmond de Rothschild Holding's 13F filing for Q4 2015, filed 16 Feb 2016.